Anika Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2015 | 77.4% | 51.8% | 33.1% |
| FY2016 | 76.8% | 49.0% | 31.5% |
| FY2017 | 75.9% | 40.3% | 28.1% |
| FY2018 | 70.4% | 20.6% | 17.7% |
| FY2019 | 74.9% | 29.9% | 23.7% |
| FY2020 | 52.9% | -21.7% | -18.4% |
| FY2021 | 56.1% | 1.8% | 2.8% |
| FY2022 | 64.3% | 3.2% | -13.1% |
| FY2023 | 68.3% | 0.7% | -68.4% |
| FY2024 | 63.4% | -4.3% | -47.0% |